Comparing the Effect of Oral Misoprostol and Intravenous Oxytocin on Labor Inductio
Phase 2
- Conditions
- Condition 1: Abdominal pregnancy. Condition 2: (Induced) termination of pregnancy with other and unspecified complications.Abdominal pregnancy(Induced) termination of pregnancy with other and unspecified complications
- Registration Number
- IRCT20171111037374N1
- Lead Sponsor
- Fasa University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 140
Inclusion Criteria
Gestational age more than 42 weeks
first and second pregnancy
women over 18 years old
singleton pregnancy,
cervical closure (Bishop score greater than six)
Exclusion Criteria
Multiple pregnancies
need for immediate cesarean section
history of uterine scarring
placenta previa
vaginal bleeding more than normal postpartum bleeding
heart, liver and kidney diseases
history of sensitivity to Oxytocin, Misoprostol or prostaglandin analogues
severe congenital anomalies in the fetus.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Delivery withing 48 hours after intervention. Timepoint: 48 hours after intervention. Method of measurement: Recording the number of patients with successful delivery within 48 hours.;Route of delivery. Timepoint: At time if delivery. Method of measurement: Recording the route of delivery (Cesarean or vaginal delivery).;Neonatal Apgar. Timepoint: 1 and 5 minutes after birth. Method of measurement: Apgar.
- Secondary Outcome Measures
Name Time Method Adverse Effects. Timepoint: 1, 2, 4, 8 and 10 days after intervention. Method of measurement: Adverse drug effects form.